Log in to save to my catalogue

High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2197327701

High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

About this item

Full title

High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Cardiology in the young, 2019-03, Vol.29 (3), p.389-397

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Shunt-related adverse events are frequent in infants after modified Blalock-Taussig despite use of acetylsalicylic acid prophylaxis. A higher incidence of acetylsalicylic acid-resistance and sub-therapeutic acetylsalicylic acid levels has been reported in infants. We evaluated whether using high-dose acetylsalicylic acid can decrease shunt-related...

Alternative Titles

Full title

High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2197327701

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2197327701

Other Identifiers

ISSN

1047-9511

E-ISSN

1467-1107

DOI

10.1017/S1047951118002536

How to access this item